Surgery Partners, Inc. Finance Lease, Right-of-Use Asset, Amortization
Surgery Partners, Inc. (SGRY) reported Finance Lease, Right-of-Use Asset, Amortization of $33.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-10
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $16.90M, a 1.81% increase year-over-year.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $16.90M, a 5.62% increase year-over-year.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $31.20M, a 113.70% increase year-over-year.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $18.10M, a 24.27% decline year-over-year.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $81.90M, a 31.88% increase from fiscal 2024.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $62.10M, a 55.64% increase from fiscal 2023.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $39.90M, a 2.84% increase from fiscal 2022.
- Surgery Partners, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $38.80M, a 54.58% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $33.80M 10-Q · filed 2026-08-10 | $65.00M derived: sum of 3 quarters · filed 2026-08-10 | $83.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $16.90M 10-Q · filed 2026-05-05 | $48.10M derived: sum of 2 quarters · filed 2026-05-05 | $66.20M derived: sum of 3 quarters · filed 2026-05-05 | $82.80M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $31.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $49.30M derived: sum of 2 quarters · filed 2026-03-02 | $65.90M derived: sum of 3 quarters · filed 2026-08-10 | $81.90M 10-K · filed 2026-03-02 |
| 2025-09-30 | $18.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $34.70M derived: sum of 2 quarters · filed 2026-08-10 | $50.70M 10-Q · filed 2025-11-10 | $65.30M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $16.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $32.60M 10-Q · filed 2026-08-10 | $47.20M derived: sum of 3 quarters · filed 2026-08-10 | $71.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $16.00M 10-Q · filed 2026-05-05 | $30.60M derived: sum of 2 quarters · filed 2026-05-05 | $54.50M derived: sum of 3 quarters · filed 2026-05-05 | $66.30M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $38.50M derived: sum of 2 quarters · filed 2026-03-02 | $50.30M derived: sum of 3 quarters · filed 2026-03-02 | $62.10M 10-K · filed 2026-03-02 |
| 2024-09-30 | $23.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $35.70M derived: sum of 2 quarters · filed 2025-11-10 | $47.50M 10-Q · filed 2025-11-10 | $58.40M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $23.60M 10-Q · filed 2025-08-05 | $34.50M derived: sum of 3 quarters · filed 2025-08-05 | $45.20M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $11.80M 10-Q · filed 2025-05-12 | $22.70M derived: sum of 2 quarters · filed 2025-05-12 | $33.40M derived: sum of 3 quarters · filed 2025-05-12 | $42.30M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $21.60M derived: sum of 2 quarters · filed 2025-03-07 | $30.50M derived: sum of 3 quarters · filed 2025-03-07 | $39.90M 10-K · filed 2025-03-07 |
| 2023-09-30 | $10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $19.60M derived: sum of 2 quarters · filed 2024-11-12 | $29.00M 10-Q · filed 2024-11-12 | $39.60M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $18.30M 10-Q · filed 2024-08-06 | $28.90M derived: sum of 3 quarters · filed 2024-08-06 | $38.20M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $9.40M 10-Q · filed 2024-05-07 | $20.00M derived: sum of 2 quarters · filed 2024-05-07 | $29.30M derived: sum of 3 quarters · filed 2024-05-07 | $39.00M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $19.90M derived: sum of 2 quarters · filed 2024-02-26 | $29.60M derived: sum of 3 quarters · filed 2024-02-26 | $38.80M 10-K · filed 2024-02-26 |
| 2022-09-30 | $9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $19.00M derived: sum of 2 quarters · filed 2023-11-07 | $28.20M 10-Q · filed 2023-11-07 | $32.90M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $18.90M 10-Q · filed 2023-08-01 | $23.60M derived: sum of 3 quarters · filed 2023-08-01 | $30.20M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $9.20M 10-Q · filed 2023-05-02 | $13.90M derived: sum of 2 quarters · filed 2023-05-02 | $20.50M derived: sum of 3 quarters · filed 2023-05-02 | $27.20M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $11.30M derived: sum of 2 quarters · filed 2023-03-01 | $18.00M derived: sum of 3 quarters · filed 2023-03-01 | $25.10M 10-K · filed 2023-03-01 |
| 2021-09-30 | $6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $13.30M derived: sum of 2 quarters · filed 2022-11-08 | $20.40M 10-Q · filed 2022-11-08 | $27.60M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $13.80M 10-Q · filed 2022-08-02 | $21.00M derived: sum of 3 quarters · filed 2022-08-02 | $28.00M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $7.10M 10-Q · filed 2022-05-03 | $14.30M derived: sum of 2 quarters · filed 2022-05-03 | $21.30M derived: sum of 3 quarters · filed 2022-05-03 | $27.40M derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $14.20M derived: sum of 2 quarters · filed 2022-03-01 | $20.30M derived: sum of 3 quarters · filed 2022-03-01 | $26.20M 10-K · filed 2022-03-01 |
| 2020-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $13.10M derived: sum of 2 quarters · filed 2021-11-03 | $19.00M 10-Q · filed 2021-11-03 | $25.90M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $12.00M 10-Q · filed 2021-08-04 | $18.90M derived: sum of 3 quarters · filed 2021-08-04 | $34.20M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $5.90M 10-Q · filed 2021-05-05 | $12.80M derived: sum of 2 quarters · filed 2021-05-05 | $28.10M derived: sum of 3 quarters · filed 2021-05-05 | $37.40M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $22.20M derived: sum of 2 quarters · filed 2021-03-10 | $31.50M derived: sum of 3 quarters · filed 2021-03-10 | $22.20M 10-K · filed 2021-03-10 |
| 2019-09-30 | $15.30M 10-Q · filed 2019-11-06 | $24.60M derived: sum of 2 quarters · filed 2019-11-06 | $15.30M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $9.30M 10-Q · filed 2019-08-09 | $9.30M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $4.50M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |